CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.01057
+0.00057 (5.70%)
At close: Aug 28, 2026
CERO Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.86 | 1.59 | 3.25 | 1.52 | 0.48 | 1.1 |
Cash & Short-Term Investments | 0.86 | 1.59 | 3.25 | 1.52 | 0.48 | 1.1 |
Cash Growth | -73.88% | -51.19% | 113.76% | 219.73% | -56.68% | - |
Prepaid Expenses | 0.61 | 1.07 | 0.27 | 0.37 | 0.23 | 0.26 |
Restricted Cash | 0.07 | 0.07 | 0.07 | 0.08 | 41.67 | - |
Other Current Assets | - | - | 0.11 | - | - | - |
Total Current Assets | 1.55 | 2.73 | 3.71 | 1.97 | 42.37 | 1.36 |
Property, Plant & Equipment | 0.35 | 0.91 | 1.99 | 3.16 | - | - |
Long-Term Deferred Tax Assets | - | - | - | - | - | 0.02 |
Long-Term Deferred Charges | - | - | 0.5 | - | - | - |
Other Long-Term Assets | - | - | - | - | - | 178.7 |
Total Assets | 1.9 | 3.64 | 6.21 | 5.13 | 42.37 | 180.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.22 | 7.58 | 4.51 | 1.67 | 1.65 | 0.01 |
Accrued Expenses | 0.44 | 0.65 | 1.86 | 0.14 | 0 | 0.08 |
Short-Term Debt | 14.97 | - | - | 0.6 | 0.65 | - |
Current Portion of Leases | 0.22 | 0.7 | 0.88 | 0.77 | - | - |
Current Income Taxes Payable | - | - | - | - | 0.6 | - |
Other Current Liabilities | 7.8 | 0.16 | 0.16 | 0.32 | 27.84 | - |
Total Current Liabilities | 32.41 | 9.09 | 7.4 | 3.51 | 30.75 | 0.1 |
Long-Term Leases | - | - | 0.7 | 1.58 | - | - |
Other Long-Term Liabilities | - | - | - | - | 22.62 | 187.65 |
Total Liabilities | 32.41 | 9.09 | 8.1 | 5.08 | 53.37 | 187.75 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 65.96 | 78.13 | 67.14 | 1.03 | - | - |
Retained Earnings | -97.75 | -90.84 | -70.92 | -43.09 | -11 | -7.67 |
Comprehensive Income & Other | -0.01 | - | -1.3 | - | - | - |
Total Common Equity | -31.79 | -12.71 | -5.07 | -42.06 | -11 | -7.67 |
Shareholders' Equity | -30.51 | -5.45 | -1.89 | 0.04 | -11 | -7.67 |
Total Liabilities & Equity | 1.9 | 3.64 | 6.21 | 5.13 | 42.37 | 180.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 15.94 | 0.7 | 1.58 | 2.94 | 0.65 | - |
Net Cash (Debt) | -15.08 | 0.89 | 1.68 | -1.42 | -0.17 | 1.1 |
Net Cash Growth | - | -47.01% | - | - | - | - |
Net Cash Per Share | -0.65 | 0.21 | 65.72 | - | -15.48 | - |
Filing Date Shares Outstanding | 71.63 | 36.79 | 0.27 | - | - | 0.01 |
Total Common Shares Outstanding | 63.81 | 21.1 | 0.12 | - | - | 0.01 |
Working Capital | -30.86 | -6.35 | -3.69 | -1.54 | 11.62 | 1.26 |
Book Value Per Share | -0.50 | -0.60 | -41.98 | - | - | -667.47 |
Tangible Book Value | -31.79 | -12.71 | -5.07 | -42.06 | -11 | -7.67 |
Tangible Book Value Per Share | -0.50 | -0.60 | -41.98 | - | - | -667.47 |
Machinery | 2.55 | 2.55 | 2.55 | 2.55 | - | - |